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The current increased interest in retinoids in oncology has
created the need for a good book reviewing this subject. This
book, edited by two highly respected workers in this field,
has on the whole come up to my high expectations. The first
chapter on biochemistry and pharmacology of retinoids is the
most complicated and most disappointing, as without very
concentrated reading it is difficult to obtain any understan-
ding of this subject. In the second chapter Reuban Lotan
describes many markers of squamous differentiation, such as
transglutaminase and envelope precursor proteins, and how
retinoids can decrease their expression in normal and malig-
nant cells. The other three preclinical chapters, on nuclear
retinoic acid receptors, growth modulation by retinoid com-
binations and in vivo use of retinoids, are excellently written
by the leaders of these fields. The multiauthor nature of this
book is highlighted by the lack of mention of N-(4-
hydroxyphenyl)retinamide in the chapter by Werner Bollag,
by the concentration on this retinoid in the chapter by
Richard Moon (where it is referred to as a 4-HPR), but it
being called fenretinide in the chapter on its clinical use for
the prevention of breast cancer.
There are good chapters on the use of retinoids in
leukaemia and myelodysplasia, in head and neck cancer, in
lung cancer, in bladder cancer, in cervical cancer, in breast
cancer and in skin cancer. Surprisingly, no mention of
melanoma is made in the chapter on skin cancer; for com-
pleteness it should be included even though clinical trials
have been negative. Amidst the clinical chapters there is one
on differentiation of human teratocarcinoma which includes
only one negative clinical trial. The excellent chapter by
Andrew Arnold on lung cancer clearly takes one through the
epidemiological studies, the animal studies, the use of
intermediate end points in human studies and some preven-
tion studies.
This book with only 338 pages cannot be comprehensive
but give a very good review of the field and clearly points
anyone contemplating working in this area to most of the
correct references. The exciting results with all-trans retinoic
acid in acute promyelocytic leukaemia and with retinoid
combinations in squamous carcinomas may have led to the
creation of this book, but both the scientist and clinician will
find many additional areas of great interest.
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